When.com Web Search

  1. Ads

    related to: inhaler asthma over the counter medication for sale

Search results

  1. Results From The WOW.Com Content Network
  2. Some drugmakers to cap cost of asthma inhalers at $35 a month

    www.aol.com/news/drugmakers-cap-cost-asthma...

    Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.

  3. Salbutamol/budesonide - Wikipedia

    en.wikipedia.org/wiki/Salbutamol/budesonide

    Salbutamol/budesonide, sold under the brand name Airsupra, is a fixed-dose combination medication for the treatment of bronchoconstriction and asthma. [1] [2] It is a combination of salbutamol sulfate (albuterol sulfate), a short-acting beta2-adrenergic agonist, and budesonide, an inhaled corticosteroid.

  4. Asthmador - Wikipedia

    en.wikipedia.org/wiki/Asthmador

    Prior to the introduction of rescue inhalers in the mid-1950s this was an over-the-counter remedy for asthma attacks. Asthmador was sold in packets like cigarettes, in tins like pipe tobacco, or as an incense. The paroxysms would abate within a few minutes of inhaling the mixture. [1] [2]

  5. Anti-asthmatic agent - Wikipedia

    en.wikipedia.org/wiki/Anti-asthmatic_agent

    The goal of asthmatic agents is to reduce asthma exacerbation frequencies and related hospital visits. Anti-asthmatic agents as rescue medications for acute asthma attacks include short-acting β 2-adrenergic receptor agonists (SABA), short-acting muscarinic antagonists (SAMA), systemic glucocorticoids, and magnesium sulfate.

  6. 22-Year-Old With Chronic Asthma Died After Inhaler Price Went ...

    www.aol.com/22-old-chronic-asthma-died-012249667...

    The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and UnitedHealth Group’s pharmacy benefit manager after they said the price for ...

  7. AstraZeneca to cap US out-of-pocket costs for inhalers at $35 ...

    www.aol.com/news/astrazeneca-cap-us-pocket-costs...

    (Reuters) -AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States, starting June, following a similar move by rival ...

  1. Ad

    related to: inhaler asthma over the counter medication for sale